Evidence map›Paper›PMID 23268334›Full record

ArticleCancer letters2013

Differential effects of grape seed extract against human colorectal cancer cell lines: the intricate role of death receptors and mitochondria.

Molly Derry, Komal Raina, Rajesh Agarwal, Chapla Agarwal

Abstract read
In one paragraph

Article in Cancer letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Phenolic Fractions fromAntioxidants (Basel, Switzerland) · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in oncology · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Lifestyle Modifications and Colorectal Cancer.Current colorectal cancer reports · 2014
    Review
  13. Article
  14. Role of oxidative stress in cytotoxicity of grape seed extract in human bladder cancer cells.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2013
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Molly DerryDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Komal RainaDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Rajesh AgarwalDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Chapla AgarwalDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: Chapla.Agarwal@UCDenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Colon Cancer Chemoprevention by Flavonoid SilibininR01CA112304 · NCI · UNIVERSITY OF COLORADO DENVER · PI AGARWAL, RAJESH · 2005 to 2015
$2.9M
Colon Cancer Chemoprevention by Grape Seed ExtractR01AT003623 · NCCIH · UNIVERSITY OF COLORADO DENVER · PI AGARWAL, CHAPLA · 2007 to 2011
$1.9M
NCCIH NIH HHS R01 AT003623NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA112304NCI NIH HHS R01CA112304
6 · The paper itself

Abstract

Failure of anti-cancer therapy in colorectal cancer (CRC) cells involves resistance to death mechanisms. We investigated grape seed extract (GSE) ability to target CRC cells and delineated the mechanisms involved in GSE-induced CRC cell death. GSE selectively induced apoptotic death in human CRC cells; efficacy increased as the metastatic potential of the cancer cells increased. Oxidative stress, loss of mitochondrial membrane potential, modulation of pro- and anti-apoptotic proteins, and involvement of both caspase-dependent/independent apoptotic pathways contributed to GSE-induced CRC cell death. GSE intervention may serve as a multi-targeted CRC therapeutic capable of inducing selective cancer cell death.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisCaspasesCell DeathCell Line, TumorColorectal NeoplasmsDrug Screening Assays, AntitumorGenes, p53Grape Seed ExtractHumansMembrane Potential, MitochondrialMitochondriaOxidative StressReceptors, TNF-Related Apoptosis-Inducing LigandAntineoplastic Agents, PhytogenicCaspasesGrape Seed ExtractReceptors, TNF-Related Apoptosis-Inducing Ligand

Identifiers

PMID23268334
PMCPMC3622127
OpenAlexW1991791423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.